Castle Biosciences, Inc.CSTLNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+32.7%/yr
Annual compound
Percentile
P88
Within normal range
vs 3Y Ago
2.3x
Strong expansion
Streak
5 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.08 | +35.6% |
| 2024 | 0.06 | +47.5% |
| 2023 | 0.04 | +16.7% |
| 2022 | 0.03 | +68.5% |
| 2021 | 0.02 | - |
| 2020 | 0.00 | -100.0% |
| 2019 | 0.30 | +112.1% |
| 2018 | -2.43 | -86.7% |
| 2017 | -1.30 | - |